Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 23% ± 8% | |
epithelial cell | 6 studies | 27% ± 9% | |
oligodendrocyte | 6 studies | 25% ± 8% | |
astrocyte | 4 studies | 31% ± 7% | |
glutamatergic neuron | 4 studies | 52% ± 22% | |
microglial cell | 3 studies | 22% ± 3% | |
lymphocyte | 3 studies | 19% ± 1% | |
GABAergic neuron | 3 studies | 53% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 31% ± 7% | |
macrophage | 3 studies | 20% ± 3% | |
basal cell | 3 studies | 21% ± 6% | |
adipocyte | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2501.35 | 1445 / 1445 | 100% | 18.93 | 183 / 183 |
lung | 100% | 2216.79 | 578 / 578 | 100% | 16.88 | 1155 / 1155 |
prostate | 100% | 2643.82 | 245 / 245 | 100% | 17.47 | 502 / 502 |
breast | 100% | 2621.97 | 459 / 459 | 100% | 25.58 | 1117 / 1118 |
brain | 100% | 1699.69 | 2637 / 2642 | 100% | 16.21 | 705 / 705 |
uterus | 100% | 2835.76 | 170 / 170 | 100% | 16.72 | 458 / 459 |
pancreas | 100% | 1743.96 | 328 / 328 | 99% | 11.70 | 177 / 178 |
bladder | 100% | 2322.10 | 21 / 21 | 99% | 14.43 | 501 / 504 |
thymus | 100% | 2563.12 | 653 / 653 | 99% | 12.77 | 600 / 605 |
ovary | 100% | 3040.69 | 180 / 180 | 99% | 9.62 | 426 / 430 |
adrenal gland | 100% | 2404.69 | 258 / 258 | 99% | 9.20 | 227 / 230 |
stomach | 100% | 2031.36 | 359 / 359 | 98% | 12.56 | 280 / 286 |
intestine | 100% | 2342.92 | 966 / 966 | 98% | 11.66 | 515 / 527 |
kidney | 100% | 1566.11 | 89 / 89 | 97% | 12.13 | 877 / 901 |
liver | 100% | 1355.71 | 226 / 226 | 97% | 8.43 | 392 / 406 |
skin | 100% | 2364.99 | 1809 / 1809 | 93% | 12.16 | 439 / 472 |
adipose | 100% | 2677.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2391.65 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.31 | 29 / 29 |
muscle | 100% | 2921.99 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2267.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.92 | 1 / 1 |
heart | 98% | 1317.57 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 1106.74 | 753 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 66% | 5.15 | 53 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0014732 | Biological process | skeletal muscle atrophy |
GO_0033574 | Biological process | response to testosterone |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0045948 | Biological process | positive regulation of translational initiation |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0071549 | Biological process | cellular response to dexamethasone stimulus |
GO_0003009 | Biological process | skeletal muscle contraction |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0009749 | Biological process | response to glucose |
GO_0007616 | Biological process | long-term memory |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0007165 | Biological process | signal transduction |
GO_0031929 | Biological process | TOR signaling |
GO_0043201 | Biological process | response to L-leucine |
GO_0031670 | Biological process | cellular response to nutrient |
GO_0033762 | Biological process | response to glucagon |
GO_0014878 | Biological process | response to electrical stimulus involved in regulation of muscle adaptation |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0034612 | Biological process | response to tumor necrosis factor |
GO_0045471 | Biological process | response to ethanol |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0014911 | Biological process | positive regulation of smooth muscle cell migration |
GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
GO_0031667 | Biological process | response to nutrient levels |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0007281 | Biological process | germ cell development |
GO_0048633 | Biological process | positive regulation of skeletal muscle tissue growth |
GO_0044539 | Biological process | long-chain fatty acid import into cell |
GO_0046324 | Biological process | regulation of glucose import |
GO_0045727 | Biological process | positive regulation of translation |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0001662 | Biological process | behavioral fear response |
GO_0006915 | Biological process | apoptotic process |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0009636 | Biological process | response to toxic substance |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0016477 | Biological process | cell migration |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0098794 | Cellular component | postsynapse |
GO_0043005 | Cellular component | neuron projection |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0051721 | Molecular function | protein phosphatase 2A binding |
GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004711 | Molecular function | ribosomal protein S6 kinase activity |
GO_0042277 | Molecular function | peptide binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RPS6KB1 |
Protein name | Ribosomal protein S6 kinase B1 RPS6KB1 protein Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) |
Synonyms | STK14A |
Description | FUNCTION: Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression . Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD . Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex . Upon mitogenic stimulation, phosphorylation by the mechanistic target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation . The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B . Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis . Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR . In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2 . Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling . Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR . Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function (By similarity). Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex . The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at Thr-412, which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function . Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1 . In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B . May be involved in cytoskeletal rearrangement through binding to neurabin (By similarity). Phosphorylates and activates the pyrimidine biosynthesis enzyme CAD, downstream of MTOR . Following activation by mTORC1, phosphorylates EPRS and thereby plays a key role in fatty acid uptake by adipocytes and also most probably in interferon-gamma-induced translation inhibition . . |
Accessions | ENST00000472940.5 ENST00000225577.9 [P23443-1] K7EMM2 ENST00000592726.1 ENST00000406116.7 [P23443-4] K7EIM2 Q4G0X7 P23443 ENST00000393021.7 [P23443-3] ENST00000443572.6 [P23443-5] ENST00000489824.1 K7ER06 |